![Yue Hsin Lin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yue Hsin Lin
Fondatore presso
LIN BIOSCIENCE, INC.
Patrimonio netto: 51 M $ in data 31/05/2026
Profilo
Yue Hsin Lin is the founder of Lin BioScience, Inc. (2016, Chairman) and Belite Bio, Inc. (2018, Chairman & Chief Executive Officer).
Current jobs include Chief Executive Officer & Director at RBP4 Pty Ltd. (2021), Chairman, President & Chief Executive Officer at Belite Bio Holdings Corp.
(2021), Director at Belite Bio (HK) Ltd. (2021), and President at Belite Bio LLC (2021).
Former jobs include Senior Director-Medical at OBI Pharma, Inc. (2010-2014), Medical Director & General Manager at Aslan Pharmaceuticals Ltd., and President & Chief Operating Officer at CVie Therapeutics Ltd. (2014-2016).
Education includes an MBA from The Trustees of Columbia University in The City of New York, an undergraduate degree from the University of Pennsylvania, an MBA from The University of Hong Kong, a doctorate from The University of Sydney, and an MBA from London Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
BELITE BIO, INC. 1,42% | 21/04/2026 | 353.883 ( 1,42% ) | 51 M $ | 31/05/2026 |
Posizioni attive di Yue Hsin Lin
| Società | Posizione | Inizio |
|---|---|---|
| LIN BIOSCIENCE, INC. | Fondatore | 12/05/2016 |
| BELITE BIO, INC | Amministratore Delegato | 27/03/2018 |
Belite Bio LLC
 Belite Bio LLC Pharmaceuticals: MajorHealth Technology Operates clinical stage biopharmaceutical drug development company | Presidente | 01/10/2021 |
RBP4 Pty Ltd. | Amministratore Delegato | 01/04/2021 |
Belite Bio Holdings Corp.
 Belite Bio Holdings Corp. Aerospace & DefenseElectronic Technology Part of Lin BioScience, Inc., Belite Bio Holdings Corp. is a clinical stage biopharmaceutical drug development company that specializes in the development of novel therapeutics for retinal degenerative eye diseases with significant unmet medical needs. The company is based in San Diego, CA. Yue Hsin Lin has been the CEO of the company since 2016. | Amministratore Delegato | 01/12/2017 |
Belite Bio (HK) Ltd. | Direttore/Membro del Consiglio | 01/06/2021 |
Precedenti posizioni note di Yue Hsin Lin
| Società | Posizione | Fine |
|---|---|---|
CVie Therapeutics Ltd.
 CVie Therapeutics Ltd. BiotechnologyHealth Technology Develops and researched drugs | Presidente | 01/01/2016 |
| OBI PHARMA, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2014 |
| ASLAN PHARMACEUTICALS LIMITED | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Yue Hsin Lin
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
12
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hong Kong
 University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London Business School
 London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OBI Pharma, Inc.
 OBI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures anti-infective and immunotherapy drugs | Health Technology |
Aslan Pharmaceuticals Ltd.
 Aslan Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops immuno-oncology agents and targeted therapies | Health Technology |
Lin BioScience, Inc.
 Lin BioScience, Inc. BiotechnologyHealth Technology Engages in discovering and development of drugs for cancer treatment and eye diseases | Health Technology |
CVie Therapeutics Ltd.
CVie Therapeutics Ltd. BiotechnologyHealth Technology Develops and researched drugs | Health Technology |
Belite Bio LLC
Belite Bio LLC Pharmaceuticals: MajorHealth Technology Operates clinical stage biopharmaceutical drug development company | Health Technology |
Belite Bio, Inc.
 Belite Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical drug development company | Health Technology |
RBP4 Pty Ltd. | |
Belite Bio Holdings Corp.
Belite Bio Holdings Corp. Aerospace & DefenseElectronic Technology Part of Lin BioScience, Inc., Belite Bio Holdings Corp. is a clinical stage biopharmaceutical drug development company that specializes in the development of novel therapeutics for retinal degenerative eye diseases with significant unmet medical needs. The company is based in San Diego, CA. Yue Hsin Lin has been the CEO of the company since 2016. | Electronic Technology |
Belite Bio (HK) Ltd. |
